Jun. 3 at 12:49 AM
$ABCL
BEST IN BREED Winners keep winning.
Buy the sector leader.
$ABCL is a 0 to 1 company. is the king of biotech.
biotech is starting to move like AI did 3 years ago
and the smart money is moving fast
- Brian Armstrong's NewLimit just hit a
$3.1B valuation
- Jeff Bezos put
$3B behind Altos Labs
- Demis Hassabis raised
$2.1B for Isomorphic Labs
- Anthropic acquired Coefficient Bio for
$400M
- NVIDIA is backing companies building programmable biology
- longevity biotech raised
$3.74B in Q1 2026 alone. 56% ahead of Q1 2025.
the interesting part is not the funding
it is what the funding is chasing
for the first time in history we are building tools that can read, model, and modify human biology at scale
Eli Lilly became one of the largest companies on earth from a single peptide category
imagine what happens when the entire stack becomes programmable
the smart money is not speculating anymore
it is positioning
Superhuman Fund II is open for whoever wants in
bio/acc
